secwatch.observer — SEC 8-K summary
======================================

Issuer:     ADIAL PHARMACEUTICALS, INC. (ADIL)
CIK:        0001513525
Form:       8-K
Filed at:   2026-04-09T23:59:59+00:00
Accession:  0001213900-26-042057
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Adial grants RSAs to CEO, CFO, COO, and directors; options to director
----------------------------------------------------------------------

- CEO Cary Claiborne receives 37,985 RSAs (28,800 as CEO, 9,185 as director).
- CFO Vinay Shah receives 17,325 RSAs; COO Tony Goodman receives 26,510 RSAs.
- Directors Schuyler and Gilliland each get 9,185 RSAs; Anderson gets options for 9,185 shares at $1.64.
- All awards vest on the earlier of one-year anniversary or change of control.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1513525/000121390026042057/0001213900-26-042057-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1513525/000121390026042057/ea0285772-8k_adial.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-042057

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer